BENZTROPINE

BENZTROPINE was reported 7432 times

BENZTROPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CLANG ASSOCIATIONS 8 0.7273
1 DYSTONIC TREMOR 27 0.3068
2 HAEMOGLOBIN URINE 7 0.1628
3 DRUG METABOLITE LEVEL HIGH 12 0.1429
4 MUSCLE TONE DISORDER 25 0.0801
5 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 12 0.0463
6 IRON METABOLISM DISORDER 5 0.0420
7 FAECALITH 5 0.0413
8 COGWHEEL RIGIDITY 40 0.0381
9 GRANULOCYTOPENIA 183 0.0321
10 EOSINOPHILIC PLEURAL EFFUSION 9 0.0302
11 THALASSAEMIA 5 0.0292
12 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 7 0.0259
13 OCULOGYRIC CRISIS 55 0.0256
14 ANTIPSYCHOTIC DRUG LEVEL DECREASED 12 0.0226
15 ANTICHOLINERGIC SYNDROME 36 0.0226
16 GLOBULINS INCREASED 8 0.0220
17 GRANDIOSITY 8 0.0219
18 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 5 0.0217
19 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 19 0.0213
20 BLOOD CREATINE PHOSPHOKINASE DECREASED 7 0.0213
21 CEREBRAL AMYLOID ANGIOPATHY 7 0.0212
22 HEAD TITUBATION 28 0.0203
23 EYE HAEMATOMA 5 0.0190
24 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 12 0.0185
25 CROUP INFECTIOUS 12 0.0152
26 SCHIZOAFFECTIVE DISORDER 26 0.0146
27 AMAUROSIS 12 0.0143
28 PROTRUSION TONGUE 8 0.0137
29 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 15 0.0136
30 POOR PERSONAL HYGIENE 7 0.0136
31 PSYCHOTIC SYMPTOM 27 0.0131
32 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 9 0.0130
33 MONOCYTOSIS 8 0.0129
34 INTENTION TREMOR 7 0.0123
35 ANHIDROSIS 5 0.0123
36 SEDATION COMPLICATION 31 0.0121
37 DELUSIONAL PERCEPTION 5 0.0120
38 EOSINOPHIL COUNT ABNORMAL 9 0.0120
39 CHOREOATHETOSIS 8 0.0118
40 TRI-IODOTHYRONINE DECREASED 6 0.0115
41 PARKINSONIAN GAIT 7 0.0112
42 C-REACTIVE PROTEIN DECREASED 7 0.0107
43 CATATONIA 56 0.0107
44 SCHIZOPHRENIA 128 0.0105
45 NEPHROGENIC DIABETES INSIPIDUS 12 0.0104
46 PSYCHIATRIC DECOMPENSATION 20 0.0102
47 MYOCARDITIS 117 0.0102
48 NEUROLEPTIC MALIGNANT SYNDROME 121 0.0102
49 RESPIRATORY TRACT INFECTION BACTERIAL 5 0.0100
50 TRISMUS 51 0.0099
51 THYROXINE DECREASED 6 0.0097
52 OROMANDIBULAR DYSTONIA 7 0.0096
53 LEFT ATRIAL DILATATION 12 0.0094
54 GASTROINTESTINAL HYPOMOTILITY 21 0.0093
55 LEFT ATRIAL ENLARGEMENT 5 0.0093
56 SOLILOQUY 8 0.0092
57 ENCEPHALITIS AUTOIMMUNE 12 0.0091
58 ANTIPSYCHOTIC DRUG LEVEL INCREASED 25 0.0089
59 BEZOAR 12 0.0087
60 ECHOCARDIOGRAM ABNORMAL 12 0.0086
61 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 22 0.0084
62 MUSCLE CONTRACTURE 17 0.0084
63 GRUNTING 5 0.0083
64 TONGUE MOVEMENT DISTURBANCE 7 0.0082
65 SUSPECTED SUICIDE 38 0.0081
66 DROOLING 56 0.0081
67 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 9 0.0081
68 PERSECUTORY DELUSION 20 0.0080
69 NEGATIVISM 6 0.0079
70 TROPONIN T INCREASED 10 0.0079
71 HALLUCINATION, AUDITORY 125 0.0079
72 DIABETIC COMA 22 0.0078
73 RESTING TREMOR 5 0.0077
74 SYSTOLIC DYSFUNCTION 8 0.0076
75 SALIVARY HYPERSECRETION 76 0.0076
76 DISORGANISED SPEECH 14 0.0076
77 STRESS URINARY INCONTINENCE 8 0.0074
78 BLOOD BICARBONATE DECREASED 14 0.0074
79 BLUNTED AFFECT 5 0.0068
80 PARKINSONISM 66 0.0068
81 DRUG LEVEL BELOW THERAPEUTIC 37 0.0067
82 CLONUS 18 0.0066
83 HYPOPARATHYROIDISM 5 0.0065
84 TARDIVE DYSKINESIA 184 0.0065
85 DYSTONIA 126 0.0065
86 MEAN CELL VOLUME DECREASED 10 0.0065
87 MUCOSAL DRYNESS 13 0.0064
88 AKATHISIA 88 0.0064
89 EXTRAPYRAMIDAL DISORDER 154 0.0062
90 TORTICOLLIS 13 0.0061
91 PSYCHOTIC DISORDER 181 0.0061
92 ILEUS PARALYTIC 27 0.0060
93 INTESTINAL DILATATION 8 0.0060
94 THERAPEUTIC AGENT TOXICITY 20 0.0060
95 IMPAIRED SELF-CARE 12 0.0058
96 FAECALOMA 31 0.0057
97 DIABETES MELLITUS NON-INSULIN-DEPENDENT 8 0.0055
98 HYPERSEXUALITY 10 0.0055
99 DIABETIC NEUROPATHY 27 0.0054
100 EXCESSIVE EYE BLINKING 8 0.0054
101 TROPONIN INCREASED 41 0.0054
102 WHITE BLOOD CELLS URINE POSITIVE 10 0.0053
103 SEDATION 138 0.0053
104 MUSCLE RIGIDITY 63 0.0053
105 COMPLETED SUICIDE 438 0.0053
106 DYSPHEMIA 23 0.0052
107 FLAT AFFECT 12 0.0052
108 GLYCOSURIA 7 0.0052
109 PCO2 DECREASED 5 0.0052
110 DILATATION ATRIAL 6 0.0051
111 ELECTROCARDIOGRAM T WAVE ABNORMAL 8 0.0051
112 BLOOD PROLACTIN INCREASED 24 0.0051
113 SINUS TACHYCARDIA 72 0.0051
114 MUCOSAL DISORDER 5 0.0050
115 PARANOIA 86 0.0050
116 REDUCED FACIAL EXPRESSION 5 0.0049
117 ACUTE PSYCHOSIS 12 0.0048
118 SEROTONIN SYNDROME 93 0.0048
119 BLOOD UREA DECREASED 6 0.0048
120 LEFT VENTRICULAR DYSFUNCTION 32 0.0048
121 HISTIOCYTOSIS HAEMATOPHAGIC 14 0.0047
122 DIABETIC COMPLICATION 12 0.0047
123 BLOOD PH DECREASED 8 0.0047
124 PRIAPISM 16 0.0046
125 HYPERAMMONAEMIC ENCEPHALOPATHY 8 0.0046
126 HYPERREFLEXIA 16 0.0046
127 DELUSION 71 0.0046
128 ASPIRATION 50 0.0046
129 AREFLEXIA 12 0.0045
130 AUTONOMIC NERVOUS SYSTEM IMBALANCE 13 0.0044
131 HOMICIDAL IDEATION 18 0.0044
132 SOMNAMBULISM 29 0.0044
133 MEAN CELL HAEMOGLOBIN DECREASED 8 0.0044
134 BIPOLAR DISORDER 47 0.0043
135 LYMPHOCYTE COUNT INCREASED 14 0.0043
136 HALLUCINATIONS, MIXED 18 0.0043
137 MUTISM 6 0.0041
138 TOOTH EROSION 5 0.0041
139 CHOREA 7 0.0041
140 BLOOD CHLORIDE INCREASED 7 0.0040
141 HYPERPROLACTINAEMIA 26 0.0040
142 IMPULSIVE BEHAVIOUR 15 0.0040
143 EXPOSURE VIA INGESTION 10 0.0040
144 TIC 21 0.0038
145 SINUS ARRHYTHMIA 5 0.0038
146 IMPAIRED GASTRIC EMPTYING 51 0.0037
147 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
148 DIABETIC NEPHROPATHY 8 0.0036
149 TOXIC ENCEPHALOPATHY 18 0.0035
150 POLYDIPSIA 14 0.0035
151 PARKINSON'S DISEASE 9 0.0035
152 HYPERLIPIDAEMIA 42 0.0035
153 TYPE 1 DIABETES MELLITUS 21 0.0035
154 JUDGEMENT IMPAIRED 5 0.0034
155 STUPOR 11 0.0034
156 COLITIS ISCHAEMIC 23 0.0034
157 COMPULSIVE SHOPPING 7 0.0034
158 TONGUE BITING 7 0.0034
159 POSTURE ABNORMAL 11 0.0034
160 TYPE 2 DIABETES MELLITUS 113 0.0034
161 GAMBLING DISORDER 9 0.0033
162 HEAT STROKE 5 0.0033
163 DYSKINESIA 131 0.0032
164 NEUTROPHIL COUNT INCREASED 33 0.0032
165 NEUTROPHILIA 18 0.0032
166 MENTAL STATUS CHANGES 87 0.0031
167 DISSOCIATION 24 0.0031
168 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
169 METABOLIC DISORDER 18 0.0031
170 SELF-INJURIOUS IDEATION 13 0.0031
171 DRUG LEVEL ABOVE THERAPEUTIC 14 0.0031
172 PERSONALITY DISORDER 8 0.0031
173 METABOLIC SYNDROME 5 0.0030
174 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10 0.0030
175 HYPERAMMONAEMIA 15 0.0030
176 OBSESSIVE-COMPULSIVE DISORDER 24 0.0030
177 POST-TRAUMATIC STRESS DISORDER 20 0.0030
178 REBOUND ACID HYPERSECRETION 9 0.0030
179 BLOOD AMYLASE INCREASED 5 0.0029
180 REFUSAL OF TREATMENT BY PATIENT 19 0.0029
181 EMOTIONAL POVERTY 5 0.0029
182 PSYCHOMOTOR RETARDATION 8 0.0028
183 SCREAMING 18 0.0028
184 DELIRIUM 98 0.0028
185 OBESITY 44 0.0028
186 MONOCYTE COUNT INCREASED 10 0.0028
187 HYPERTHERMIA 21 0.0027
188 BIPOLAR I DISORDER 6 0.0027
189 ESSENTIAL HYPERTENSION 5 0.0027
190 ABNORMAL BEHAVIOUR 108 0.0027
191 CLOSTRIDIUM TEST POSITIVE 6 0.0027
192 HIGH DENSITY LIPOPROTEIN DECREASED 9 0.0027
193 TREATMENT NONCOMPLIANCE 146 0.0027
194 METABOLIC ENCEPHALOPATHY 8 0.0027
195 BLOOD TRIGLYCERIDES INCREASED 47 0.0027
196 CARDIOMYOPATHY 39 0.0026
197 MULTIPLE DRUG OVERDOSE 13 0.0026
198 BUNDLE BRANCH BLOCK RIGHT 12 0.0026
199 TACHYPHRENIA 9 0.0026
200 DIASTOLIC DYSFUNCTION 8 0.0026
201 MYDRIASIS 33 0.0026
202 CLUMSINESS 7 0.0026
203 URINARY HESITATION 6 0.0025
204 BLOOD CREATINE PHOSPHOKINASE INCREASED 72 0.0025
205 DRUG WITHDRAWAL SYNDROME NEONATAL 37 0.0025
206 MANIA 41 0.0025
207 DIABETES INSIPIDUS 6 0.0025
208 TOXICITY TO VARIOUS AGENTS 419 0.0025
209 ENURESIS 10 0.0025
210 INCOHERENT 16 0.0025
211 RESTLESSNESS 90 0.0025
212 HYPOMANIA 9 0.0024
213 MYOCLONUS 29 0.0024
214 IMPULSE-CONTROL DISORDER 5 0.0024
215 HYPERPARATHYROIDISM 5 0.0024
216 GASTROINTESTINAL NECROSIS 7 0.0024
217 POTENTIATING DRUG INTERACTION 8 0.0024
218 DRUG LEVEL INCREASED 39 0.0024
219 DIABETIC RETINOPATHY 8 0.0024
220 ORTHOSTATIC HYPOTENSION 41 0.0024
221 AMMONIA INCREASED 12 0.0023
222 EYE MOVEMENT DISORDER 16 0.0023
223 BLOOD CHLORIDE DECREASED 6 0.0023
224 DIABETES MELLITUS 177 0.0023
225 MENTAL DISORDER 99 0.0023
226 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
227 CEREBRAL ATROPHY 9 0.0023
228 AGGRESSION 113 0.0023
229 HYPERPHAGIA 9 0.0023
230 ALCOHOL ABUSE 6 0.0022
231 DRUG INTERACTION 355 0.0022
232 DYSARTHRIA 84 0.0022
233 MULTIPLE DRUG OVERDOSE INTENTIONAL 7 0.0022
234 TORSADE DE POINTES 17 0.0022
235 DRUG LEVEL DECREASED 22 0.0022
236 AGITATION 158 0.0021
237 THINKING ABNORMAL 40 0.0021
238 BLOOD ALBUMIN DECREASED 17 0.0021
239 FACIAL PARALYSIS 18 0.0021
240 ATAXIA 25 0.0021
241 AGRANULOCYTOSIS 39 0.0021
242 PERICARDITIS 35 0.0021
243 DIABETIC KETOACIDOSIS 50 0.0021
244 NYSTAGMUS 11 0.0021
245 STARING 5 0.0021
246 SLOW SPEECH 5 0.0021
247 HYPERTRIGLYCERIDAEMIA 12 0.0020
248 MITRAL VALVE INCOMPETENCE 23 0.0020
249 ELECTROCARDIOGRAM QT PROLONGED 72 0.0020
250 BRAIN INJURY 20 0.0020
251 MUSCLE CONTRACTIONS INVOLUNTARY 7 0.0020
252 LOSS OF EMPLOYMENT 6 0.0020
253 ECONOMIC PROBLEM 30 0.0020
254 FIBRIN D DIMER INCREASED 7 0.0020
255 SELF INJURIOUS BEHAVIOUR 6 0.0020
256 PNEUMONIA ASPIRATION 49 0.0020
257 MASTICATION DISORDER 6 0.0020
258 DIZZINESS POSTURAL 19 0.0020
259 TREMOR 324 0.0020
260 TONGUE DISORDER 14 0.0019
261 WRONG PRODUCT ADMINISTERED 13 0.0019
262 END STAGE RENAL DISEASE 35 0.0019
263 BLOOD PHOSPHORUS DECREASED 7 0.0019
264 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
265 SOCIAL AVOIDANT BEHAVIOUR 11 0.0019
266 HALLUCINATION, VISUAL 40 0.0019
267 TESTICULAR PAIN 6 0.0019
268 RESTLESS LEGS SYNDROME 34 0.0019
269 GALACTORRHOEA 12 0.0019
270 MOTOR DYSFUNCTION 19 0.0019
271 ENERGY INCREASED 11 0.0019
272 UNRESPONSIVE TO STIMULI 48 0.0019
273 BRUXISM 10 0.0019
274 BLOOD SODIUM INCREASED 5 0.0019
275 MUSCLE STRAIN 16 0.0018
276 COMMUNICATION DISORDER 7 0.0018
277 DEAFNESS NEUROSENSORY 6 0.0018
278 HYPERNATRAEMIA 9 0.0018
279 WHITE BLOOD CELL COUNT INCREASED 69 0.0018
280 ELECTRIC SHOCK SENSATION 5 0.0018
281 ENDOTRACHEAL INTUBATION 5 0.0018
282 MAJOR DEPRESSION 13 0.0018
283 DYSPHORIA 9 0.0018
284 DYSLIPIDAEMIA 9 0.0018
285 CARDIO-RESPIRATORY ARREST 74 0.0018
286 TACHYCARDIA 156 0.0018
287 POISONING 22 0.0017
288 DIABETES MELLITUS INADEQUATE CONTROL 30 0.0017
289 RESPIRATORY RATE INCREASED 15 0.0017
290 DRUG TOXICITY 23 0.0017
291 SUICIDAL BEHAVIOUR 7 0.0017
292 HALLUCINATION 125 0.0017
293 RHABDOMYOLYSIS 69 0.0017
294 LEUKOPENIA 82 0.0016
295 SUICIDAL IDEATION 150 0.0016
296 BLOOD THYROID STIMULATING HORMONE INCREASED 15 0.0016
297 HEART RATE ABNORMAL 9 0.0016
298 CARDIAC DYSFUNCTION 6 0.0016
299 ILEUS 20 0.0016
300 TUBULOINTERSTITIAL NEPHRITIS 30 0.0016
301 BLOOD CREATININE DECREASED 5 0.0016
302 RESPIRATORY ARREST 44 0.0016
303 BLEPHAROSPASM 10 0.0016
304 HYPERTONIA 9 0.0016
305 EXPOSURE TO TOXIC AGENT 5 0.0016
306 MUSCLE TWITCHING 36 0.0016
307 HYPERCHOLESTEROLAEMIA 15 0.0016
308 HAEMOGLOBIN INCREASED 7 0.0015
309 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
310 VITAMIN D DECREASED 13 0.0015
311 COGNITIVE DISORDER 71 0.0015
312 PERFORMANCE STATUS DECREASED 7 0.0015
313 CONFUSIONAL STATE 241 0.0015
314 LACERATION 14 0.0015
315 SYRINGE ISSUE 26 0.0015
316 URINARY RETENTION 49 0.0015
317 ENCEPHALOPATHY 36 0.0015
318 BLOOD CHOLESTEROL INCREASED 68 0.0015
319 DRUG ABUSE 121 0.0015
320 INTESTINAL ISCHAEMIA 8 0.0015
321 VIITH NERVE PARALYSIS 5 0.0014
322 PRESCRIBED OVERDOSE 28 0.0014
323 DEPRESSION SUICIDAL 5 0.0014
324 CARDIAC ARREST 119 0.0014
325 CONGESTIVE CARDIOMYOPATHY 6 0.0014
326 INTENTIONAL OVERDOSE 92 0.0014
327 LOGORRHOEA 5 0.0014
328 EJECTION FRACTION DECREASED 22 0.0014
329 NICOTINE DEPENDENCE 11 0.0014
330 MENTAL IMPAIRMENT 34 0.0014
331 HYPERGLYCAEMIA 51 0.0014
332 AFFECTIVE DISORDER 11 0.0014
333 FACIAL BONES FRACTURE 5 0.0014
334 BLOOD URIC ACID INCREASED 8 0.0014
335 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
336 HYPOTHERMIA 14 0.0014
337 HYPOVOLAEMIA 8 0.0014
338 BRADYKINESIA 8 0.0014
339 PSYCHIATRIC SYMPTOM 10 0.0014
340 SUICIDE ATTEMPT 81 0.0013
341 ANAL INCONTINENCE 12 0.0013
342 IRON DEFICIENCY 6 0.0013
343 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
344 CHRONIC SINUSITIS 5 0.0013
345 PREMATURE BABY 40 0.0013
346 LEUKOCYTOSIS 24 0.0013
347 RENAL TUBULAR NECROSIS 13 0.0013
348 EOSINOPHIL COUNT INCREASED 11 0.0013
349 HAEMATOCRIT DECREASED 26 0.0013
350 CLAVICLE FRACTURE 5 0.0013
351 ISCHAEMIA 6 0.0013
352 FEELING OF DESPAIR 6 0.0013
353 PRE-EXISTING CONDITION IMPROVED 8 0.0013
354 NONSPECIFIC REACTION 7 0.0013
355 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
356 HEAD INJURY 40 0.0013
357 TRICUSPID VALVE INCOMPETENCE 10 0.0013
358 SPINAL OSTEOARTHRITIS 11 0.0013
359 PERONEAL NERVE PALSY 7 0.0012
360 THERAPY CHANGE 12 0.0012
361 COORDINATION ABNORMAL 17 0.0012
362 URINARY INCONTINENCE 36 0.0012
363 HYPOPHAGIA 31 0.0012
364 CRYING 44 0.0012
365 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
366 SLEEP APNOEA SYNDROME 23 0.0012
367 STRESS CARDIOMYOPATHY 7 0.0012
368 SKIN WARM 7 0.0012
369 HEPATIC ENZYME ABNORMAL 6 0.0012
370 FLUID INTAKE REDUCED 6 0.0012
371 CHRONIC KIDNEY DISEASE 91 0.0012
372 GRAND MAL CONVULSION 11 0.0012
373 DECREASED INTEREST 7 0.0012
374 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
375 PERSONALITY CHANGE 11 0.0012
376 DEMENTIA 33 0.0012
377 BUNDLE BRANCH BLOCK LEFT 5 0.0012
378 PROTHROMBIN TIME PROLONGED 7 0.0012
379 GYNAECOMASTIA 36 0.0012
380 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
381 BLOOD CALCIUM DECREASED 13 0.0012
382 SPEECH DISORDER 60 0.0011
383 FOOD CRAVING 6 0.0011
384 INTENTIONAL SELF-INJURY 23 0.0011
385 BLOOD UREA INCREASED 19 0.0011
386 SUDDEN DEATH 12 0.0011
387 BLOOD CREATINE INCREASED 5 0.0011
388 WHEELCHAIR USER 5 0.0011
389 RHINITIS ALLERGIC 5 0.0011
390 OVERWEIGHT 6 0.0011
391 INTESTINAL OBSTRUCTION 42 0.0011
392 BLOOD SODIUM DECREASED 21 0.0011
393 SUBSTANCE ABUSE 9 0.0011
394 POLYURIA 9 0.0011
395 DRY MOUTH 89 0.0011
396 ANGER 37 0.0011
397 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
398 NEPHROGENIC ANAEMIA 5 0.0011
399 C-REACTIVE PROTEIN INCREASED 39 0.0011
400 KETOACIDOSIS 8 0.0011
401 WEIGHT INCREASED 239 0.0011
402 RESPIRATORY DEPRESSION 13 0.0011
403 PRESCRIBED UNDERDOSE 21 0.0011
404 NEUROLOGICAL SYMPTOM 6 0.0010
405 HYPERSOMNIA 30 0.0010
406 BOWEL MOVEMENT IRREGULARITY 8 0.0010
407 LETHARGY 60 0.0010
408 INCONTINENCE 11 0.0010
409 MUSCULOSKELETAL STIFFNESS 91 0.0010
410 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23 0.0010
411 ATELECTASIS 10 0.0010
412 HYPOKINESIA 15 0.0010
413 NEEDLE ISSUE 30 0.0010
414 BODY TEMPERATURE INCREASED 21 0.0010
415 DRUG RESISTANCE 26 0.0010
416 SKIN LACERATION 11 0.0010
417 DISORIENTATION 40 0.0010
418 HYPOMAGNESAEMIA 14 0.0010
419 SLEEP DISORDER 70 0.0010
420 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
421 THERMAL BURN 7 0.0010
422 SOMNOLENCE 197 0.0010
423 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
424 CYST 12 0.0010
425 HEPATIC STEATOSIS 18 0.0010
426 NEUTROPHIL COUNT DECREASED 39 0.0010
427 ARTERIOSCLEROSIS 9 0.0010
428 BRAIN OEDEMA 12 0.0009
429 CONSTIPATION 207 0.0009
430 CEREBRAL DISORDER 7 0.0009
431 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
432 DEPRESSION 214 0.0009
433 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
434 DYSPHAGIA 89 0.0009
435 POOR QUALITY SLEEP 20 0.0009
436 HOSPICE CARE 9 0.0009
437 RED BLOOD CELL COUNT DECREASED 26 0.0009
438 HYPERKERATOSIS 5 0.0009
439 WITHDRAWAL SYNDROME 38 0.0009
440 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
441 DENTAL CARIES 10 0.0009
442 MOVEMENT DISORDER 29 0.0009
443 CARDIOTOXICITY 8 0.0009
444 FEAR 24 0.0009
445 SEIZURE 103 0.0009
446 PRODUCT LEAKAGE 5 0.0009
447 DISTURBANCE IN ATTENTION 48 0.0009
448 TACHYPNOEA 12 0.0009
449 DERMATITIS CONTACT 10 0.0009
450 EMOTIONAL DISORDER 27 0.0009
451 CHOKING 17 0.0009
452 MUSCLE TIGHTNESS 14 0.0009
453 HYPERTRANSAMINASAEMIA 6 0.0009
454 FORMICATION 6 0.0009
455 AMNESIA 56 0.0009
456 NEPHROPATHY 8 0.0009
457 CONVULSION 49 0.0009
458 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
459 SPLENOMEGALY 10 0.0009
460 HIATUS HERNIA 11 0.0008
461 HAND FRACTURE 6 0.0008
462 PANCREATITIS ACUTE 19 0.0008
463 ODYNOPHAGIA 5 0.0008
464 INCREASED APPETITE 16 0.0008
465 ANHEDONIA 22 0.0008
466 DRUG USE DISORDER 7 0.0008
467 ALANINE AMINOTRANSFERASE INCREASED 51 0.0008
468 PANIC ATTACK 30 0.0008
469 APATHY 12 0.0008
470 DISEASE RECURRENCE 39 0.0008
471 MOUTH HAEMORRHAGE 6 0.0008
472 MEMORY IMPAIRMENT 112 0.0008
473 METABOLIC ACIDOSIS 26 0.0008
474 CARDIOMEGALY 10 0.0008
475 BLOOD MAGNESIUM DECREASED 7 0.0008
476 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
477 SKIN INFECTION 9 0.0008
478 AMENORRHOEA 14 0.0008
479 EATING DISORDER 17 0.0008
480 BREAST TENDERNESS 6 0.0008
481 LUNG INFILTRATION 7 0.0008
482 MYOCARDIAL ISCHAEMIA 9 0.0008
483 BALANCE DISORDER 68 0.0008
484 SLUGGISHNESS 8 0.0008
485 IRRITABILITY 47 0.0008
486 RENAL FAILURE CHRONIC 6 0.0008
487 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
488 ERECTILE DYSFUNCTION 20 0.0008
489 THERAPY PARTIAL RESPONDER 12 0.0008
490 HYPOXIA 27 0.0008
491 FALL 255 0.0008
492 DRUG SCREEN POSITIVE 6 0.0008
493 PULMONARY CONGESTION 10 0.0008
494 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
495 NEUTROPENIA 103 0.0008
496 FURUNCLE 6 0.0008
497 PANCREATITIS 40 0.0008
498 JOINT DISLOCATION 8 0.0008
499 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
500 RENAL CYST 6 0.0008
501 LOSS OF CONSCIOUSNESS 96 0.0007
502 ACUTE KIDNEY INJURY 114 0.0007
503 SHOCK 17 0.0007
504 BLOOD POTASSIUM INCREASED 12 0.0007
505 ANXIETY 210 0.0007
506 PRODUCT PACKAGING ISSUE 7 0.0007
507 HYPOKALAEMIA 34 0.0007
508 LYMPHOCYTE COUNT DECREASED 13 0.0007
509 THERAPY NON-RESPONDER 33 0.0007
510 MOOD ALTERED 20 0.0007
511 SMALL INTESTINAL OBSTRUCTION 9 0.0007
512 APHASIA 22 0.0007
513 AFFECT LABILITY 7 0.0007
514 RESPIRATION ABNORMAL 5 0.0007
515 OSTEOPENIA 11 0.0007
516 VENTRICULAR FIBRILLATION 8 0.0007
517 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 51 0.0007
518 MALNUTRITION 8 0.0007
519 HAEMODIALYSIS 6 0.0007
520 COMA 34 0.0007
521 ANKLE FRACTURE 11 0.0007
522 HEMIPARESIS 12 0.0007
523 RENAL FAILURE 94 0.0007
524 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
525 RENAL FAILURE ACUTE 30 0.0007
526 INABILITY TO AFFORD MEDICATION 7 0.0007
527 SWOLLEN TONGUE 22 0.0007
528 DEPRESSED MOOD 37 0.0007
529 PANIC REACTION 5 0.0007
530 PRODUCT ADMINISTRATION ERROR 14 0.0007
531 DEVICE LEAKAGE 30 0.0007
532 GAIT DISTURBANCE 132 0.0007
533 ELECTROLYTE IMBALANCE 8 0.0007
534 TOOTH ABSCESS 7 0.0007
535 RESPIRATORY FAILURE 50 0.0007
536 EOSINOPHILIA 12 0.0007
537 EUPHORIC MOOD 7 0.0007
538 INSOMNIA 182 0.0007
539 OVERDOSE 147 0.0007
540 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
541 RENAL INJURY 20 0.0007
542 VISION BLURRED 92 0.0007
543 ADVERSE DRUG REACTION 60 0.0007
544 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 32 0.0007
545 DRUG ADMINISTERED AT INAPPROPRIATE SITE 7 0.0007
546 HEPATITIS C 8 0.0007
547 FULL BLOOD COUNT ABNORMAL 7 0.0007
548 RETCHING 14 0.0007
549 WHITE BLOOD CELL COUNT DECREASED 71 0.0007
550 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 12 0.0007
551 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
552 NERVOUSNESS 34 0.0007
553 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
554 PERICARDIAL EFFUSION 15 0.0006
555 CONDITION AGGRAVATED 197 0.0006
556 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
557 MUSCULOSKELETAL CHEST PAIN 10 0.0006
558 GASTROOESOPHAGEAL REFLUX DISEASE 52 0.0006
559 HEPATIC ENCEPHALOPATHY 6 0.0006
560 TOOTH EXTRACTION 8 0.0006
561 NERVOUS SYSTEM DISORDER 20 0.0006
562 PRODUCT USE IN UNAPPROVED INDICATION 158 0.0006
563 SEPSIS 70 0.0006
564 MOOD SWINGS 20 0.0006
565 HYPERKALAEMIA 22 0.0006
566 LOWER LIMB FRACTURE 12 0.0006
567 INTENTIONAL DRUG MISUSE 13 0.0006
568 URINARY TRACT INFECTION 106 0.0006
569 ANOREXIA 8 0.0006
570 SINUS BRADYCARDIA 6 0.0006
571 MUSCLE DISORDER 5 0.0006
572 MICTURITION URGENCY 7 0.0006
573 ASPHYXIA 5 0.0006
574 NIGHTMARE 21 0.0006
575 DISABILITY 12 0.0006
576 HYPOTONIA 6 0.0006
577 SEPTIC SHOCK 26 0.0006
578 QUALITY OF LIFE DECREASED 8 0.0006
579 FEEDING DISORDER 12 0.0006
580 BACTERAEMIA 7 0.0006
581 PHARYNGEAL OEDEMA 9 0.0006
582 DEHYDRATION 78 0.0006
583 RIB FRACTURE 12 0.0006
584 PRODUCT CONTAINER ISSUE 5 0.0006
585 DYSSTASIA 17 0.0006
586 HYPOTENSION 116 0.0006
587 CARDIAC MURMUR 5 0.0006
588 MEDICATION ERROR 32 0.0006
589 DRUG DOSE OMISSION 94 0.0006
590 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
591 BLOOD CREATININE INCREASED 37 0.0006
592 ABASIA 14 0.0006
593 BRADYCARDIA 30 0.0006
594 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
595 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
596 EAR INFECTION 15 0.0006
597 PARALYSIS 8 0.0006
598 CARDIOGENIC SHOCK 8 0.0006
599 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
600 DECREASED ACTIVITY 6 0.0006
601 TOOTHACHE 10 0.0006
602 HYPERTENSION 117 0.0006
603 CHEST PAIN 102 0.0006
604 OESOPHAGITIS 6 0.0005
605 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
606 HOSPITALISATION 84 0.0005
607 VENTRICULAR TACHYCARDIA 9 0.0005
608 TOOTH FRACTURE 6 0.0005
609 DEFORMITY 5 0.0005
610 PRESYNCOPE 13 0.0005
611 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
612 CYSTITIS 17 0.0005
613 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
614 FLANK PAIN 5 0.0005
615 REBOUND EFFECT 6 0.0005
616 LEUKAEMIA 5 0.0005
617 UNEVALUABLE EVENT 40 0.0005
618 IMPAIRED DRIVING ABILITY 6 0.0005
619 POISONING DELIBERATE 5 0.0005
620 LACTIC ACIDOSIS 17 0.0005
621 CAESAREAN SECTION 6 0.0005
622 VITAMIN D DEFICIENCY 5 0.0005
623 SEXUAL DYSFUNCTION 6 0.0005
624 PHARYNGEAL SWELLING 5 0.0005
625 LIGAMENT SPRAIN 5 0.0005
626 HEART RATE INCREASED 50 0.0005
627 BLADDER DISORDER 5 0.0005
628 INTENTIONAL PRODUCT MISUSE 44 0.0005
629 WRIST FRACTURE 6 0.0005
630 CARPAL TUNNEL SYNDROME 7 0.0005
631 INJURY 35 0.0005
632 EMPHYSEMA 5 0.0005
633 EMOTIONAL DISTRESS 60 0.0005
634 DRUG EFFECT INCOMPLETE 18 0.0005
635 LYMPHOPENIA 7 0.0005
636 NOCTURIA 6 0.0005
637 DIALYSIS 7 0.0005
638 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
639 HYPERHIDROSIS 63 0.0005
640 DYSURIA 18 0.0005
641 CHOLELITHIASIS 16 0.0005
642 BLOOD GLUCOSE ABNORMAL 9 0.0005
643 HEART RATE IRREGULAR 11 0.0005
644 PHARYNGITIS 6 0.0005
645 LIVER FUNCTION TEST ABNORMAL 14 0.0005
646 TENDERNESS 5 0.0005
647 PRODUCT DOSE OMISSION 31 0.0005
648 HYPOGLYCAEMIA 23 0.0005
649 MUSCLE ATROPHY 6 0.0005
650 HAEMATEMESIS 12 0.0005
651 DIZZINESS 236 0.0005
652 CIRCULATORY COLLAPSE 8 0.0005
653 HAEMOGLOBIN DECREASED 48 0.0005
654 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
655 PLATELET COUNT INCREASED 6 0.0005
656 NODULE 6 0.0005
657 PRODUCT PRESCRIBING ISSUE 10 0.0005
658 BLOOD PRESSURE FLUCTUATION 11 0.0005
659 RASH MACULAR 16 0.0005
660 GASTRITIS 12 0.0005
661 HYPOAESTHESIA 68 0.0005
662 PNEUMONIA 147 0.0005
663 PULMONARY EMBOLISM 43 0.0005
664 FIBROMYALGIA 11 0.0005
665 HEAD DISCOMFORT 8 0.0005
666 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
667 THERAPY CESSATION 23 0.0004
668 THIRST 8 0.0004
669 PYREXIA 152 0.0004
670 OSTEOPOROSIS 18 0.0004
671 BLOOD PRESSURE DECREASED 29 0.0004
672 VOMITING 205 0.0004
673 BLOOD POTASSIUM DECREASED 13 0.0004
674 HUNGER 6 0.0004
675 OFF LABEL USE 377 0.0004
676 CORONARY ARTERY DISEASE 13 0.0004
677 MIDDLE INSOMNIA 8 0.0004
678 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
679 DYSPHONIA 25 0.0004
680 DRUG EFFECT DECREASED 23 0.0004
681 DEVICE OCCLUSION 6 0.0004
682 HYPONATRAEMIA 24 0.0004
683 BLOOD PRESSURE INCREASED 65 0.0004
684 SEASONAL ALLERGY 6 0.0004
685 DIPLOPIA 11 0.0004
686 WEIGHT DECREASED 118 0.0004
687 HYPOCALCAEMIA 8 0.0004
688 FOOT FRACTURE 8 0.0004
689 BLOOD IRON DECREASED 5 0.0004
690 IMPAIRED WORK ABILITY 9 0.0004
691 CHOLECYSTITIS 5 0.0004
692 ACCIDENT 5 0.0004
693 CELLULITIS 21 0.0004
694 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
695 ACUTE RESPIRATORY FAILURE 8 0.0004
696 FACE OEDEMA 7 0.0004
697 HERNIA 8 0.0004
698 PRODUCT DISPENSING ERROR 9 0.0004
699 UNDERDOSE 30 0.0004
700 HAEMORRHOIDS 8 0.0004
701 ACCIDENTAL OVERDOSE 15 0.0004
702 NO THERAPEUTIC RESPONSE 5 0.0004
703 SCAR 7 0.0004
704 BLOOD BILIRUBIN INCREASED 11 0.0004
705 HYPOTHYROIDISM 13 0.0004
706 ACUTE MYOCARDIAL INFARCTION 12 0.0004
707 ABNORMAL WEIGHT GAIN 5 0.0004
708 RASH MACULO-PAPULAR 9 0.0004
709 PULMONARY OEDEMA 18 0.0004
710 HAIR COLOUR CHANGES 5 0.0004
711 NEUROTOXICITY 7 0.0004
712 SPINAL FRACTURE 8 0.0004
713 BONE LOSS 6 0.0004
714 HYPOAESTHESIA ORAL 6 0.0004
715 THROMBOCYTOPENIA 44 0.0004
716 FEELING ABNORMAL 94 0.0004
717 THERAPY INTERRUPTED 28 0.0004
718 NASAL CONGESTION 23 0.0004
719 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
720 DRUG ADMINISTRATION ERROR 12 0.0004
721 VIRAL INFECTION 13 0.0004
722 OROPHARYNGEAL PAIN 36 0.0004
723 LIMB DISCOMFORT 12 0.0004
724 TENDONITIS 6 0.0004
725 DEATH 333 0.0004
726 POLLAKIURIA 16 0.0004
727 ABDOMINAL DISTENSION 40 0.0004
728 BRAIN FOG 6 0.0004
729 ROAD TRAFFIC ACCIDENT 16 0.0004
730 SYNCOPE 38 0.0004
731 THERAPEUTIC RESPONSE DECREASED 23 0.0004
732 PLEURAL EFFUSION 23 0.0004
733 OSTEOARTHRITIS 16 0.0004
734 EYE SWELLING 14 0.0004
735 MUSCLE SPASMS 69 0.0004
736 HAIR TEXTURE ABNORMAL 5 0.0004
737 LIVER FUNCTION TEST INCREASED 8 0.0004
738 ASTHMA 42 0.0004
739 PRODUCT DOSE OMISSION ISSUE 109 0.0004
740 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
741 ACUTE HEPATIC FAILURE 5 0.0004
742 RENAL DISORDER 17 0.0004
743 TREATMENT FAILURE 30 0.0004
744 MUSCULAR WEAKNESS 41 0.0004
745 NECK PAIN 20 0.0004
746 WOUND 10 0.0004
747 MASS 5 0.0004
748 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
749 OXYGEN SATURATION DECREASED 20 0.0004
750 DRUG INEFFECTIVE 469 0.0004
751 DYSPEPSIA 35 0.0004
752 CHROMATURIA 8 0.0004
753 DRUG WITHDRAWAL SYNDROME 31 0.0004
754 CATARACT 21 0.0004
755 INFLUENZA LIKE ILLNESS 29 0.0004
756 INTENTIONAL DOSE OMISSION 10 0.0004
757 RASH GENERALISED 9 0.0003
758 HAEMATOMA 9 0.0003
759 PRODUCT PHYSICAL ISSUE 7 0.0003
760 PARAESTHESIA ORAL 5 0.0003
761 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
762 DRUG ERUPTION 6 0.0003
763 ARRHYTHMIA 16 0.0003
764 BRONCHITIS 25 0.0003
765 SKIN HAEMORRHAGE 5 0.0003
766 PULMONARY HYPERTENSION 7 0.0003
767 EYE DISORDER 11 0.0003
768 RESPIRATORY DISORDER 10 0.0003
769 PALPITATIONS 39 0.0003
770 ASTHENIA 125 0.0003
771 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
772 LIMB INJURY 9 0.0003
773 VISUAL ACUITY REDUCED 11 0.0003
774 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
775 PELVIC PAIN 6 0.0003
776 BONE DISORDER 6 0.0003
777 JOINT INJURY 7 0.0003
778 INSURANCE ISSUE 5 0.0003
779 TINNITUS 15 0.0003
780 RECTAL HAEMORRHAGE 14 0.0003
781 MIGRAINE 31 0.0003
782 FEELING COLD 9 0.0003
783 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 58 0.0003
784 PHOTOPHOBIA 6 0.0003
785 BLOOD GLUCOSE INCREASED 60 0.0003
786 ATRIAL FIBRILLATION 31 0.0003
787 PRODUCT USE COMPLAINT 5 0.0003
788 FATIGUE 247 0.0003
789 ABDOMINAL PAIN LOWER 8 0.0003
790 FEELING JITTERY 6 0.0003
791 TRANSAMINASES INCREASED 7 0.0003
792 HEPATOTOXICITY 7 0.0003
793 ULCER 5 0.0003
794 ANGINA PECTORIS 9 0.0003
795 OEDEMA 17 0.0003
796 HEPATITIS 8 0.0003
797 DRUG PRESCRIBING ERROR 6 0.0003
798 NAUSEA 247 0.0003
799 MYALGIA 53 0.0003
800 HIP FRACTURE 10 0.0003
801 NIGHT SWEATS 10 0.0003
802 PLATELET COUNT DECREASED 33 0.0003
803 SKIN ULCER 8 0.0003
804 HEPATIC ENZYME INCREASED 21 0.0003
805 DEEP VEIN THROMBOSIS 20 0.0003
806 MUSCULOSKELETAL PAIN 16 0.0003
807 JOINT STIFFNESS 8 0.0003
808 NEUROPATHY PERIPHERAL 29 0.0003
809 ABDOMINAL DISCOMFORT 51 0.0003
810 STAPHYLOCOCCAL INFECTION 10 0.0003
811 PHOTOSENSITIVITY REACTION 5 0.0003
812 DECREASED APPETITE 70 0.0003
813 BACK PAIN 70 0.0003
814 COAGULOPATHY 5 0.0003
815 FUNGAL INFECTION 10 0.0003
816 CHILLS 35 0.0003
817 HEADACHE 187 0.0003
818 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
819 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
820 OCULAR HYPERAEMIA 14 0.0003
821 PRODUCT QUALITY ISSUE 40 0.0003
822 BLINDNESS 12 0.0003
823 EPILEPSY 9 0.0003
824 PRODUCT PRESCRIBING ERROR 7 0.0003
825 FEMUR FRACTURE 9 0.0003
826 MUSCULOSKELETAL DISCOMFORT 5 0.0003
827 ABNORMAL DREAMS 8 0.0003
828 TOOTH LOSS 6 0.0003
829 MULTI-ORGAN FAILURE 5 0.0003
830 CARDIAC DISORDER 27 0.0003
831 EYE PAIN 16 0.0003
832 SINUSITIS 29 0.0003
833 DYSPNOEA 160 0.0003
834 VISUAL IMPAIRMENT 35 0.0003
835 ADVERSE EVENT 26 0.0003
836 COUGH 79 0.0003
837 OEDEMA PERIPHERAL 34 0.0003
838 ABDOMINAL PAIN UPPER 57 0.0003
839 HAEMATOCHEZIA 15 0.0003
840 PSORIATIC ARTHROPATHY 11 0.0003
841 DEVICE BREAKAGE 11 0.0003
842 CONTUSION 26 0.0003
843 TOOTH DISORDER 6 0.0003
844 GAIT INABILITY 9 0.0003
845 PANCYTOPENIA 15 0.0003
846 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
847 ANAEMIA 51 0.0003
848 ABDOMINAL PAIN 62 0.0003
849 HEPATIC CIRRHOSIS 5 0.0003
850 PRODUCT USE ISSUE 50 0.0003
851 PAIN IN EXTREMITY 78 0.0003
852 MOBILITY DECREASED 19 0.0003
853 MYOCARDIAL INFARCTION 46 0.0003
854 PRODUCT AVAILABILITY ISSUE 6 0.0003
855 PROTEINURIA 5 0.0003
856 DRUG INTOLERANCE 25 0.0003
857 MALAISE 113 0.0003
858 EAR PAIN 5 0.0003
859 DEVICE MALFUNCTION 18 0.0003
860 BONE PAIN 15 0.0003
861 PAIN 157 0.0003
862 BONE DENSITY DECREASED 8 0.0003
863 DRUG-INDUCED LIVER INJURY 8 0.0003
864 LYMPHADENOPATHY 9 0.0003
865 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
866 PRODUCTIVE COUGH 12 0.0003
867 INFLUENZA 28 0.0003
868 RASH ERYTHEMATOUS 12 0.0003
869 UPPER LIMB FRACTURE 5 0.0003
870 CEREBROVASCULAR ACCIDENT 42 0.0002
871 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
872 EXTRA DOSE ADMINISTERED 10 0.0002
873 NEURALGIA 6 0.0002
874 TASTE DISORDER 5 0.0002
875 INJECTION SITE MASS 9 0.0002
876 ILLNESS 25 0.0002
877 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
878 LIP SWELLING 8 0.0002
879 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
880 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
881 INCORRECT DOSE ADMINISTERED 54 0.0002
882 FLUID RETENTION 12 0.0002
883 DIARRHOEA 152 0.0002
884 GASTROINTESTINAL DISORDER 21 0.0002
885 PERIPHERAL SWELLING 36 0.0002
886 HAEMATURIA 8 0.0002
887 IRRITABLE BOWEL SYNDROME 5 0.0002
888 RHINORRHOEA 15 0.0002
889 PRURITUS GENERALISED 5 0.0002
890 HAEMORRHAGE 24 0.0002
891 ARTHRITIS 18 0.0002
892 FEELING HOT 14 0.0002
893 BURNING SENSATION 16 0.0002
894 NASOPHARYNGITIS 42 0.0002
895 MELAENA 5 0.0002
896 CHEST DISCOMFORT 23 0.0002
897 LUNG DISORDER 11 0.0002
898 SWELLING 21 0.0002
899 RASH 97 0.0002
900 SURGERY 13 0.0002
901 HYPERSENSITIVITY 41 0.0002
902 PALLOR 6 0.0002
903 SKIN DISCOLOURATION 10 0.0002
904 COVID-19 38 0.0002
905 SWELLING FACE 14 0.0002
906 VERTIGO 13 0.0002
907 IMPAIRED HEALING 7 0.0002
908 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
909 CARDIAC FAILURE CONGESTIVE 17 0.0002
910 THROMBOSIS 17 0.0002
911 PARAESTHESIA 33 0.0002
912 VAGINAL HAEMORRHAGE 9 0.0002
913 FLUSHING 21 0.0002
914 PRURITUS 78 0.0002
915 AGEUSIA 5 0.0002
916 DRY EYE 10 0.0002
917 ANAPHYLACTIC REACTION 11 0.0002
918 HEPATIC FAILURE 6 0.0002
919 PRODUCT COMPLAINT 5 0.0002
920 URTICARIA 33 0.0002
921 DISCOMFORT 12 0.0002
922 ARTHRALGIA 81 0.0002
923 LUNG NEOPLASM MALIGNANT 8 0.0002
924 INFECTION 28 0.0002
925 EXPOSURE DURING PREGNANCY 12 0.0002
926 RESPIRATORY TRACT INFECTION 5 0.0002
927 EYE IRRITATION 11 0.0002
928 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
929 INJECTION SITE REACTION 13 0.0002
930 MENSTRUATION IRREGULAR 5 0.0002
931 WHEEZING 11 0.0002
932 ERYTHEMA 38 0.0002
933 THROAT TIGHTNESS 5 0.0002
934 SKIN LESION 5 0.0002
935 RESPIRATORY DISTRESS 5 0.0002
936 EXPIRED PRODUCT ADMINISTERED 6 0.0002
937 SKIN DISORDER 6 0.0002
938 HAEMOPTYSIS 5 0.0002
939 BLISTER 10 0.0002
940 DYSGEUSIA 13 0.0002
941 GASTRIC DISORDER 6 0.0002
942 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
943 EPISTAXIS 13 0.0002
944 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
945 HEART RATE DECREASED 6 0.0002
946 PSORIASIS 22 0.0002
947 MULTIPLE SCLEROSIS 8 0.0002
948 RENAL IMPAIRMENT 14 0.0002
949 BLOOD GLUCOSE DECREASED 8 0.0002
950 JOINT SWELLING 20 0.0002
951 NEOPLASM MALIGNANT 11 0.0002
952 ILL-DEFINED DISORDER 10 0.0002
953 HYPOACUSIS 7 0.0002
954 ARTHROPATHY 9 0.0002
955 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
956 DYSPNOEA EXERTIONAL 6 0.0002
957 PRODUCT SUBSTITUTION ISSUE 9 0.0002
958 THROAT IRRITATION 7 0.0002
959 SKIN EXFOLIATION 13 0.0002
960 INJECTION SITE PAIN 47 0.0002
961 ABORTION SPONTANEOUS 6 0.0001
962 CARDIAC FAILURE 12 0.0001
963 STOMATITIS 9 0.0001
964 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
965 RASH PRURITIC 8 0.0001
966 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
967 HOT FLUSH 11 0.0001
968 PRODUCT ADHESION ISSUE 5 0.0001
969 CEREBRAL HAEMORRHAGE 5 0.0001
970 INJECTION SITE HAEMORRHAGE 11 0.0001
971 FEBRILE NEUTROPENIA 9 0.0001
972 ANGIOEDEMA 6 0.0001
973 LIVER DISORDER 6 0.0001
974 COLITIS 5 0.0001
975 NO ADVERSE EVENT 22 0.0001
976 INFLAMMATION 6 0.0001
977 INJECTION SITE BRUISING 9 0.0001
978 ALOPECIA 22 0.0001
979 NEPHROLITHIASIS 5 0.0001
980 FLATULENCE 6 0.0001
981 HERPES ZOSTER 6 0.0001
982 DRUG DEPENDENCE 16 0.0001
983 ACNE 7 0.0001
984 DRY SKIN 12 0.0001
985 DEVICE ISSUE 8 0.0001
986 INJECTION SITE ERYTHEMA 10 0.0001
987 DEVICE EXPULSION 5 0.0001
988 DISEASE PROGRESSION 9 0.0001
989 PRODUCT STORAGE ERROR 6 0.0001
990 INJECTION SITE SWELLING 5 0.0001
991 BREAST CANCER 6 0.0001
992 MALIGNANT NEOPLASM PROGRESSION 5 0.0000